Enveric Biosciences (ENVB) Stock Chart & Stock Price History $1.25 +0.01 (+0.40%) As of 07/3/2025 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enveric Biosciences Stock Price Performance The Enveric Biosciences (ENVB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.84%, with a year-to-date return of -76.66%. In the past month, the stock has decreased 2.71%, reflecting recent market activity. As of the latest close, Enveric Biosciences traded at $1.26 with a market cap of $3.10 million and volume of 35,571 shares. Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.21%1 Month Performance-2.71%3 Month Performance+3.72%Year-To-Date Performance-76.66%1 Year Performance-83.84% ENVB Stock Chart for Friday, July, 4, 2025 ENVB Chart by TradingView Enveric Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$1.25$1.26+0.40%$1.28$1.2435,571 shs$3.10 million07/02/2025$1.23$1.25+1.63%$1.26$1.2334,676 shs$3.09 million07/01/2025$1.21$1.23+1.65%$1.25$1.2067,012 shs$3.04 million06/30/2025$1.24$1.21-2.42%$1.25$1.19118,424 shs$2.99 million06/27/2025$1.27$1.24-2.36%$1.32$1.23467,769 shs$3.06 million06/26/2025$1.24$1.27+2.42%$1.28$1.2255,696 shs$3.14 million06/25/2025$1.25$1.24-0.80%$1.27$1.2261,018 shs$3.06 million06/24/2025$1.25$1.25$1.35$1.20305,165 shs$3.09 million06/23/2025$1.27$1.25-1.57%$1.30$1.2159,191 shs$3.09 million06/20/2025$1.26$1.27+0.79%$1.31$1.26101,067 shs$3.14 million Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$1.26$1.26$1.31$1.24125,017 shs$3.12 million06/18/2025$1.25$1.26+0.80%$1.31$1.24125,017 shs$3.11 million06/17/2025$1.27$1.25-1.57%$1.29$1.2365,404 shs$3.09 million06/16/2025$1.21$1.27+4.96%$1.30$1.23129,033 shs$3.14 million06/13/2025$1.24$1.21-2.42%$1.22$1.18100,804 shs$2.99 million06/12/2025$1.23$1.24+0.81%$1.26$1.2162,742 shs$3.07 million06/11/2025$1.28$1.23-3.91%$1.31$1.23136,341 shs$3.04 million06/10/2025$1.30$1.28-1.54%$1.30$1.22779,825 shs$3.16 million06/09/2025$1.30$1.30$1.36$1.30122,289 shs$3.21 million06/06/2025$1.26$1.30+3.17%$1.33$1.2666,079 shs$3.21 million06/05/2025$1.29$1.26-2.33%$1.34$1.25165,436 shs$3.12 million06/04/2025$1.27$1.29+1.57%$1.31$1.23118,803 shs$3.19 million06/03/2025$1.23$1.27+3.25%$1.33$1.21515,120 shs$3.14 million Related Companies TRIB Stock Price Chart ATHA Stock Price Chart BGXX Stock Price Chart BCDA Stock Price Chart EQ Stock Price Chart SNSE Stock Price Chart LPTX Stock Price Chart BTAI Stock Price Chart XFOR Stock Price Chart PHXM Stock Price Chart Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENVB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
